Jeffrey Thomas Yorio, Aviva G. Asnis-Alibozek, Vijay Kasturi, & Thomas E. Hutson. (2024). Estimated cost of VEGFR TKI associated adverse events in metastatic renal cell carcinoma patients. BMC.
Chicago Style (17th ed.) CitationJeffrey Thomas Yorio, Aviva G. Asnis-Alibozek, Vijay Kasturi, and Thomas E. Hutson. Estimated Cost of VEGFR TKI Associated Adverse Events in Metastatic Renal Cell Carcinoma Patients. BMC, 2024.
MLA (9th ed.) CitationJeffrey Thomas Yorio, et al. Estimated Cost of VEGFR TKI Associated Adverse Events in Metastatic Renal Cell Carcinoma Patients. BMC, 2024.
Warning: These citations may not always be 100% accurate.